Chromosome 9p21 Loss and p16 Inactivation in Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma-Reference-Cited by-同舟云学术

Chromosome 9p21 Loss and p16 Inactivation in Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma

Published:1999-06 Issue:1 Volume:84 Page:88-93
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Ahrendt Steven A.,Eisenberger Claus F.,Yip Lin,Rashid Asif,Chow John T.,Pitt Henry A.,Sidransky David

Publisher

Elsevier BV

Subject

Surgery

Reference38 articles.

1. Ahrendt, S. A. Pitt, H. A. Nakeeb, A. Klein, A. S. Lillemoe, K. D. Kalloo, A. N. Cameron, J. L. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis, J. Gastrointest. Surg.

2. Cholangiocarcinoma complicating primary sclerosing cholangitis;Rosen;Ann. Surg.,1991

3. Primary sclerosing cholangitis: Liver transplantation or biliary surgery;Farges;Surgery,1995

4. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case–control study;Bergquist;Hepatology,1998

5. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis;Broome;Gut,1996

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis;Gastrointestinal Endoscopy;2023-03

2. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients;Human Pathology;2022-08

3. DNA methylation profile of liver tissue in end-stage cholestatic liver disease;Epigenomics;2022-04

4. Characteristics of head and neck squamous cell carcinoma cell Lines reflect human tumor biology independent of primary etiologies and HPV status;Translational Oncology;2020-10

5. Current omics-based biomarkers for cholangiocarcinoma;Expert Review of Molecular Diagnostics;2019-10-01